title: Fatal bowel infarction due to aspergillosis after chemotherapy.
authors.affiliation: Institut Paoli-Calmettes, Université de la Méditerranée, Marseille, France. ouaissi_mehdi@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Ouaïssi
authors.forename: V
authors.initials: V
authors.lastname: Moutardier
authors.forename: O
authors.initials: O
authors.lastname: Emungania
authors.forename: B
authors.initials: B
authors.lastname: Lelong
authors.forename: J M
authors.initials: JM
authors.lastname: Forel
authors.forename: J
authors.initials: J
authors.lastname: Guiramand
authors.forename: O
authors.initials: O
authors.lastname: Turrini
authors.forename: J R
authors.initials: JR
authors.lastname: Delpero
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001228:Aspergillosis / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D001232:Aspergillus fumigatus; D017809:Fatal Outcome; D006801:Humans; D007077:Ileal Diseases / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D007082:Ileum / Q000098:blood supply*; D007238:Infarction / Q000382:microbiology*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012852:Sinusitis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents